Cargando…
Dedifferentiation and neuronal repression define familial Alzheimer’s disease
Identifying the systems-level mechanisms that lead to Alzheimer’s disease, an unmet need, is an essential step toward the development of therapeutics. In this work, we report that the key disease-causative mechanisms, including dedifferentiation and repression of neuronal identity, are triggered by...
Autores principales: | Caldwell, Andrew B., Liu, Qing, Schroth, Gary P., Galasko, Douglas R., Yuan, Shauna H., Wagner, Steven L., Subramaniam, Shankar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673760/ https://www.ncbi.nlm.nih.gov/pubmed/33188013 http://dx.doi.org/10.1126/sciadv.aba5933 |
Ejemplares similares
-
Endotype reversal as a novel strategy for screening drugs targeting familial Alzheimer's disease
por: Caldwell, Andrew B., et al.
Publicado: (2022) -
Transcriptomic profiling of sporadic Alzheimer’s disease patients
por: Caldwell, Andrew B., et al.
Publicado: (2022) -
Limitations of the human iPSC-derived neuron model for early-onset Alzheimer’s disease
por: Valdes, Phoebe, et al.
Publicado: (2023) -
A Myt1 family transcription factor defines neuronal fate by repressing non-neuronal genes
por: Lee, Joo, et al.
Publicado: (2019) -
Endotype Characterization Reveals Mechanistic Differences Across Brain Regions in Sporadic Alzheimer’s Disease
por: Patel, Ashay O., et al.
Publicado: (2023)